AAV-CRISPR/Cas9 genome editing of VEGFR2 for treating ocular diseases Grant US-11541072-B2 United States of America 03 Jan 2023
Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with… Grant US-11338019-B2 United States of America 24 May 2022